SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

NuCana Reports Third Quarter 2026 Financial Results and Provides Business Update

Development Programme for NUC-7738 Advances with Three Presentations Planned at ESMO Immuno-Oncology

NCNA

Related stories